Contract Research Services

ImQuest BioSciences is a preclinical contract research and development organization (CRO) that provides services to evaluate the potential of new and novel pharmaceutical products for the treatment and prevention of viruses, bacteria, cancer and inflammatory diseases.

As part of our ImQuest SUCCESS platform, we provide expert preclinical research services, including compound screening to define compound efficacy and drug target validation analysis to define the mechanism of action and toxicity of pharmaceutical products. We specialize in the development of small molecules, natural products, biologics, antimicrobial peptides, therapeutic antibodies and vaccines for infectious disease and cancer drug development programs.

Our preclinical contract research services are comprised of interrelated efficacy-defining components for infectious disease (including microbiology and virology), cancer and women's health with parallel evaluations of in vitro and ex vivo toxicity and the pharmaceutical properties and chemical structure of preclinical candidates to efficiently validate you drug target.

We are committed to earning our client's trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. Our team has decades of experience in the field of virology, microbiology and oncology. As such, we understand that each product and each client is unique and we strive to provide effective solutions. Learn More.

Contact Us to request a quote for infectious disease and cancer preclinical services. Connect with us on LinkedIn and Facebook.

What's New

  • Combination Therapy Key to Fighting Bacterial Infections

    Current antibiotic treatments include using one or two drugs to fight an infection, and these treatments are becoming less and less effective as bacteria and other pathogens continue to develop and spread resistance mechanisms against them.

    Blog Articles


  • ImQuest on the Road in Boston

    October 15th-October 23rd, 2018
    Contact Us to Schedule a Meeting With Our Team
  • Preclinical Contract Research Services

    Frederick, MD

Meet the Team

ImQuest virology microbiology infectious disease CRO

Robert W. Buckheit, Jr., Ph.D.

President and CSO

Dr. Buckheit received a B.S. in Biology from Lehigh University in 1982, a Ph.D. in Microbiology and Immunology from Duke University in 1986, and

Our Team